FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2133140570> ?p ?o ?g. }

• W2133140570 endingPage "2144" @default.
• W2133140570 startingPage "2137" @default.
• W2133140570 abstract "Objectives Immunoglobulin (Ig) free light chains (FLCs) are short-lived B cell products that contribute to inflammation in several experimental disease models. In this study, FLC concentrations in inflamed joints of patients with rheumatoid arthritis (RA) as compared to patients with osteoarthritis were investigated. In addition, the relationship of FLCs and disease activity upon B cell depletion (rituximab) in patients with RA was studied. Methods Synovial fluid (SF) and tissue from patients with RA were analysed for local presence of FLCs using ELISA and immunohistochemistry. In addition, FLC concentrations were measured (at baseline, 3 and 6 months after treatment) in 50 patients with RA with active disease who were treated with rituximab. Changes in FLCs were correlated to changes in disease activity and compared to alterations in IgM, IgG, IgA, IgM-rheumatoid factor (RF) and IgG-anti-citrullinated protein antibody (ACPA) concentrations. Results FLCs were detected in synovial tissue from patients with RA, and high FLC concentrations were found in SF from inflamed joints, which positively correlate with serum FLC concentrations. Serum FLC concentrations significantly correlated with disease activity score using 28 joint counts, erythrocyte sedimentation rate (ESR) and C reactive protein, and changes in FLC correlated with clinical improvement after rituximab treatment. Moreover, effect of treatment on FLC concentrations discriminated clinical responders from non-responders, whereas IgM-RF and IgG-ACPA significantly decreased in both patient groups. Conclusions FLCs are abundantly present in inflamed joints and FLC levels correlate with disease activity. The correlation of FLC concentrations and disease activity indicates that FLCs may be relevant biomarkers for treatment response to rituximab in patients with RA and suggests that targeting FLC may be of importance in the therapy of RA." @default.
• W2133140570 created "2016-06-24" @default.
• W2133140570 creator A5012564728 @default.
• W2133140570 creator A5030765087 @default.
• W2133140570 creator A5039255500 @default.
• W2133140570 creator A5047702224 @default.
• W2133140570 creator A5055406124 @default.
• W2133140570 creator A5062753391 @default.
• W2133140570 creator A5063928355 @default.
• W2133140570 creator A5066337948 @default.
• W2133140570 creator A5082114687 @default.
• W2133140570 creator A5083934651 @default.
• W2133140570 date "2010-08-02" @default.
• W2133140570 modified "2023-09-27" @default.
• W2133140570 title "Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity" @default.
• W2133140570 cites W1498806091 @default.
• W2133140570 cites W1525177589 @default.
• W2133140570 cites W1854514017 @default.
• W2133140570 cites W1982709334 @default.
• W2133140570 cites W1985380203 @default.
• W2133140570 cites W1990426435 @default.
• W2133140570 cites W1993847760 @default.
• W2133140570 cites W2000905503 @default.
• W2133140570 cites W2003414137 @default.
• W2133140570 cites W2019554345 @default.
• W2133140570 cites W2024644107 @default.
• W2133140570 cites W2025851689 @default.
• W2133140570 cites W2027789508 @default.
• W2133140570 cites W2031694038 @default.
• W2133140570 cites W2059125686 @default.
• W2133140570 cites W2060217136 @default.
• W2133140570 cites W2063800157 @default.
• W2133140570 cites W2065122053 @default.
• W2133140570 cites W2066459080 @default.
• W2133140570 cites W2077158310 @default.
• W2133140570 cites W2080731522 @default.
• W2133140570 cites W2081127262 @default.
• W2133140570 cites W2102230755 @default.
• W2133140570 cites W2103021172 @default.
• W2133140570 cites W2106171259 @default.
• W2133140570 cites W2108498093 @default.
• W2133140570 cites W2110882920 @default.
• W2133140570 cites W2118173089 @default.
• W2133140570 cites W2118285475 @default.
• W2133140570 cites W2140579827 @default.
• W2133140570 cites W2152348310 @default.
• W2133140570 cites W2154315688 @default.
• W2133140570 cites W2157547519 @default.
• W2133140570 cites W2167446675 @default.
• W2133140570 doi "https://doi.org/10.1136/ard.2009.126441" @default.
• W2133140570 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20679475" @default.
• W2133140570 hasPublicationYear "2010" @default.
• W2133140570 type Work @default.
• W2133140570 sameAs 2133140570 @default.
• W2133140570 citedByCount "62" @default.
• W2133140570 countsByYear W21331405702012 @default.
• W2133140570 countsByYear W21331405702013 @default.
• W2133140570 countsByYear W21331405702014 @default.
• W2133140570 countsByYear W21331405702015 @default.
• W2133140570 countsByYear W21331405702016 @default.
• W2133140570 countsByYear W21331405702017 @default.
• W2133140570 countsByYear W21331405702018 @default.
• W2133140570 countsByYear W21331405702019 @default.
• W2133140570 countsByYear W21331405702020 @default.
• W2133140570 countsByYear W21331405702021 @default.
• W2133140570 countsByYear W21331405702022 @default.
• W2133140570 countsByYear W21331405702023 @default.
• W2133140570 crossrefType "journal-article" @default.
• W2133140570 hasAuthorship W2133140570A5012564728 @default.
• W2133140570 hasAuthorship W2133140570A5030765087 @default.
• W2133140570 hasAuthorship W2133140570A5039255500 @default.
• W2133140570 hasAuthorship W2133140570A5047702224 @default.
• W2133140570 hasAuthorship W2133140570A5055406124 @default.
• W2133140570 hasAuthorship W2133140570A5062753391 @default.
• W2133140570 hasAuthorship W2133140570A5063928355 @default.
• W2133140570 hasAuthorship W2133140570A5066337948 @default.
• W2133140570 hasAuthorship W2133140570A5082114687 @default.
• W2133140570 hasAuthorship W2133140570A5083934651 @default.
• W2133140570 hasBestOaLocation W21331405702 @default.
• W2133140570 hasConcept C126322002 @default.
• W2133140570 hasConcept C159654299 @default.
• W2133140570 hasConcept C18031839 @default.
• W2133140570 hasConcept C198451711 @default.
• W2133140570 hasConcept C203014093 @default.
• W2133140570 hasConcept C2776232647 @default.
• W2133140570 hasConcept C2776914184 @default.
• W2133140570 hasConcept C2777575956 @default.
• W2133140570 hasConcept C2778143017 @default.
• W2133140570 hasConcept C2780653079 @default.
• W2133140570 hasConcept C2781195455 @default.
• W2133140570 hasConcept C71924100 @default.
• W2133140570 hasConcept C90924648 @default.
• W2133140570 hasConceptScore W2133140570C126322002 @default.
• W2133140570 hasConceptScore W2133140570C159654299 @default.
• W2133140570 hasConceptScore W2133140570C18031839 @default.
• W2133140570 hasConceptScore W2133140570C198451711 @default.
• W2133140570 hasConceptScore W2133140570C203014093 @default.
• W2133140570 hasConceptScore W2133140570C2776232647 @default.

• next